CA Stock MarketDetailed Quotes

HBP Helix BioPharma Corp

Watchlist
  • 0.790
  • -0.050-5.95%
15min DelayPost Market Nov 27 11:39 ET
38.73MMarket Cap-752P/E (TTM)

Helix BioPharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.56%-5.22M
51.46%-747K
25.13%-1.13M
-39.01%-1.52M
-31.42%-1.83M
15.09%-5.53M
15.35%-1.54M
7.10%-1.5M
20.64%-1.09M
17.94%-1.39M
Net income from continuing operations
-47.28%-9.26M
-145.03%-5.28M
-36.06%-1.83M
23.88%-902K
21.92%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.00%-1.35M
41.31%-1.19M
11.42%-1.61M
Operating gains losses
1,133.33%31K
133.33%6K
172.73%8K
--5K
-53.85%12K
-133.33%-3K
-28.57%-18K
---11K
--0
966.67%26K
Depreciation and amortization
7.69%14K
-25.00%3K
33.33%4K
0.00%3K
33.33%4K
8.33%13K
33.33%4K
0.00%3K
0.00%3K
0.00%3K
Remuneration paid in stock
517.75%3.52M
772.22%3.45M
-82.35%6K
-82.93%21K
112.50%34K
33.88%569K
1,031.43%396K
-57.50%34K
-49.80%123K
-75.38%16K
Other non cashItems
----
----
----
----
-2,500.00%-24K
----
----
----
----
--1K
Change In working capital
162.16%485K
358.37%1.07M
470.81%686K
-1,854.55%-645K
-467.06%-624K
120.74%185K
150.65%233K
72.75%-185K
-110.61%-33K
365.63%170K
-Change in receivables
-96.31%8K
-33.33%34K
-212.50%-25K
0.00%6K
-104.17%-7K
193.24%217K
-27.14%51K
73.33%-8K
160.00%6K
281.82%168K
-Change in prepaid assets
-624.32%-194K
65.00%-7K
-256.56%-191K
-15.38%22K
80.22%-18K
157.81%37K
79.59%-20K
165.22%122K
204.00%26K
-800.00%-91K
-Change in payables and accrued expense
1,072.46%671K
-33.57%93K
369.62%852K
-4,907.14%-673K
329.03%399K
92.35%-69K
132.41%140K
54.53%-316K
-95.95%14K
176.86%93K
-Change in other current liabilities
----
----
194.12%50K
--0
---998K
----
----
--17K
---79K
--0
Cash from discontinued investing activities
Operating cash flow
5.56%-5.22M
51.40%-748K
25.20%-1.13M
-36.69%-1.49M
-33.24%-1.85M
15.10%-5.53M
15.39%-1.54M
7.10%-1.5M
20.57%-1.09M
17.99%-1.39M
Investing cash flow
Cash flow from continuing investing activities
-180.00%-14K
-150.00%-2K
0
0
-100.00%-12K
-5K
4K
0
-3K
-6K
Net PPE purchase and sale
-180.00%-14K
-150.00%-2K
--0
--0
-100.00%-12K
---5K
--4K
--0
---3K
---6K
Cash from discontinued investing activities
Investing cash flow
-180.00%-14K
-150.00%-2K
--0
--0
-100.00%-12K
---5K
--4K
--0
---3K
---6K
Financing cash flow
Cash flow from continuing financing activities
78.36%5.51M
9.82%1.1M
1.72M
100.21%1K
4.64%2.69M
-50.25%3.09M
-68.57%998K
0
-478K
2.57M
Net issuance payments of debt
--0
--0
--0
--0
--0
---2.06M
--406K
--0
--0
---2.47M
Net common stock issuance
32.64%5.51M
369.95%1.1M
--1.72M
-99.98%1K
561.58%2.69M
38.64%4.15M
-4,411.11%-406K
--0
--4.15M
--406K
Net other financing activities
----
----
----
----
----
--998K
----
----
----
--4.63M
Cash from discontinued financing activities
Financing cash flow
78.36%5.51M
9.82%1.1M
--1.72M
100.21%1K
4.64%2.69M
-50.25%3.09M
-68.57%998K
--0
---478K
--2.57M
Net cash flow
Beginning cash position
-75.15%808K
-46.62%710K
-95.75%120K
-62.68%1.64M
-75.15%808K
-8.78%3.25M
-29.33%1.33M
499.36%2.82M
134.76%4.4M
-8.78%3.25M
Current changes in cash
111.17%273K
164.43%346K
139.76%598K
3.68%-1.52M
-27.84%845K
-703.95%-2.44M
-139.60%-537K
-206.59%-1.5M
-14.39%-1.57M
169.09%1.17M
Effect of exchange rate changes
----
----
-172.73%-8K
---5K
53.85%-12K
----
----
--11K
--0
-966.67%-26K
End cash Position
33.79%1.08M
33.79%1.08M
-46.62%710K
-95.75%120K
-62.68%1.64M
-75.15%808K
-75.15%808K
-29.33%1.33M
499.36%2.82M
134.76%4.4M
Free cash from
5.47%-5.23M
51.30%-750K
25.20%-1.13M
-36.31%-1.49M
-33.52%-1.86M
14.95%-5.54M
15.34%-1.54M
7.10%-1.5M
20.35%-1.1M
17.64%-1.4M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.56%-5.22M51.46%-747K25.13%-1.13M-39.01%-1.52M-31.42%-1.83M15.09%-5.53M15.35%-1.54M7.10%-1.5M20.64%-1.09M17.94%-1.39M
Net income from continuing operations -47.28%-9.26M-145.03%-5.28M-36.06%-1.83M23.88%-902K21.92%-1.25M4.16%-6.29M-55.41%-2.15M0.00%-1.35M41.31%-1.19M11.42%-1.61M
Operating gains losses 1,133.33%31K133.33%6K172.73%8K--5K-53.85%12K-133.33%-3K-28.57%-18K---11K--0966.67%26K
Depreciation and amortization 7.69%14K-25.00%3K33.33%4K0.00%3K33.33%4K8.33%13K33.33%4K0.00%3K0.00%3K0.00%3K
Remuneration paid in stock 517.75%3.52M772.22%3.45M-82.35%6K-82.93%21K112.50%34K33.88%569K1,031.43%396K-57.50%34K-49.80%123K-75.38%16K
Other non cashItems -----------------2,500.00%-24K------------------1K
Change In working capital 162.16%485K358.37%1.07M470.81%686K-1,854.55%-645K-467.06%-624K120.74%185K150.65%233K72.75%-185K-110.61%-33K365.63%170K
-Change in receivables -96.31%8K-33.33%34K-212.50%-25K0.00%6K-104.17%-7K193.24%217K-27.14%51K73.33%-8K160.00%6K281.82%168K
-Change in prepaid assets -624.32%-194K65.00%-7K-256.56%-191K-15.38%22K80.22%-18K157.81%37K79.59%-20K165.22%122K204.00%26K-800.00%-91K
-Change in payables and accrued expense 1,072.46%671K-33.57%93K369.62%852K-4,907.14%-673K329.03%399K92.35%-69K132.41%140K54.53%-316K-95.95%14K176.86%93K
-Change in other current liabilities --------194.12%50K--0---998K----------17K---79K--0
Cash from discontinued investing activities
Operating cash flow 5.56%-5.22M51.40%-748K25.20%-1.13M-36.69%-1.49M-33.24%-1.85M15.10%-5.53M15.39%-1.54M7.10%-1.5M20.57%-1.09M17.99%-1.39M
Investing cash flow
Cash flow from continuing investing activities -180.00%-14K-150.00%-2K00-100.00%-12K-5K4K0-3K-6K
Net PPE purchase and sale -180.00%-14K-150.00%-2K--0--0-100.00%-12K---5K--4K--0---3K---6K
Cash from discontinued investing activities
Investing cash flow -180.00%-14K-150.00%-2K--0--0-100.00%-12K---5K--4K--0---3K---6K
Financing cash flow
Cash flow from continuing financing activities 78.36%5.51M9.82%1.1M1.72M100.21%1K4.64%2.69M-50.25%3.09M-68.57%998K0-478K2.57M
Net issuance payments of debt --0--0--0--0--0---2.06M--406K--0--0---2.47M
Net common stock issuance 32.64%5.51M369.95%1.1M--1.72M-99.98%1K561.58%2.69M38.64%4.15M-4,411.11%-406K--0--4.15M--406K
Net other financing activities ----------------------998K--------------4.63M
Cash from discontinued financing activities
Financing cash flow 78.36%5.51M9.82%1.1M--1.72M100.21%1K4.64%2.69M-50.25%3.09M-68.57%998K--0---478K--2.57M
Net cash flow
Beginning cash position -75.15%808K-46.62%710K-95.75%120K-62.68%1.64M-75.15%808K-8.78%3.25M-29.33%1.33M499.36%2.82M134.76%4.4M-8.78%3.25M
Current changes in cash 111.17%273K164.43%346K139.76%598K3.68%-1.52M-27.84%845K-703.95%-2.44M-139.60%-537K-206.59%-1.5M-14.39%-1.57M169.09%1.17M
Effect of exchange rate changes ---------172.73%-8K---5K53.85%-12K----------11K--0-966.67%-26K
End cash Position 33.79%1.08M33.79%1.08M-46.62%710K-95.75%120K-62.68%1.64M-75.15%808K-75.15%808K-29.33%1.33M499.36%2.82M134.76%4.4M
Free cash from 5.47%-5.23M51.30%-750K25.20%-1.13M-36.31%-1.49M-33.52%-1.86M14.95%-5.54M15.34%-1.54M7.10%-1.5M20.35%-1.1M17.64%-1.4M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data